Biodesix (BDSX) Non-Current Assets (2019 - 2026)

Biodesix (BDSX) has reported Non-Current Assets for 8 consecutive years, with $53.7 million the latest figure, recorded in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $53.7 million, down 5.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.7 million (down 5.11% YoY), and the FY2025 annual result was $55.0 million, down 4.85% from the prior year.
• Non-Current Assets was $53.7 million for Q1 2026 at Biodesix, down from $55.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $59.4 million in Q4 2023 and troughed at $34.4 million in Q1 2022.
• Average Non-Current Assets over 5 years is $51.7 million, with a median of $55.3 million recorded in 2025.
• Year-over-year, Non-Current Assets surged 50.14% in 2023 and retreated 5.8% in 2025.
• Over 5 years, Non-Current Assets stood at $39.6 million in 2022, then soared by 50.14% to $59.4 million in 2023, then decreased by 2.78% to $57.8 million in 2024, then declined by 4.85% to $55.0 million in 2025, then fell by 2.24% to $53.7 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $53.7 million in Q1 2026, $55.0 million in Q4 2025, and $55.3 million in Q3 2025.